SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Wigren Jan)
 

Sökning: WFRF:(Wigren Jan) > Pathogenic immunity...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003815naa a2200361 4500
001oai:lup.lub.lu.se:8a8a09e5-4031-457a-8d80-7ef33b70a93a
003SwePub
008160401s2015 | |||||||||||000 ||eng|
024a https://lup.lub.lu.se/record/51426332 URI
024a https://doi.org/10.1111/joim.123572 DOI
040 a (SwePub)lu
041 a engb eng
042 9 SwePub
072 7a for2 swepub-publicationtype
072 7a ref2 swepub-contenttype
100a Wigren, Mariau Lund University,Lunds universitet,Kardiovaskulär forskning - immunitet och ateroskleros,Forskargrupper vid Lunds universitet,Cardiovascular Research - Immunity and Atherosclerosis,Lund University Research Groups4 aut0 (Swepub:lu)med-mbr
2451 0a Pathogenic immunity in systemic lupus erythematous and atherosclerosis: common mechanisms and possible targets for intervention.
264 c 2015-10-19
264 1b Wiley,c 2015
338 a electronic2 rdacarrier
520 a Systemic lupus erythematous (SLE) is an autoimmune disorder that primarily affects young women and is characterized by inflammation in several organs including the kidneys, skin, joints, blood, and nervous system. Abnormal immune cellular and humoral responses play important roles in the development of the disease process. Impaired clearance of apoptotic material is a key factor contributing to activation of self-reactive immune cells. The incidence of atherosclerotic cardiovascular disease (CVD) is increased up to 50-fold in SLE patients compared to age- and gender-matched control subjects and this can only partly be explained by traditional risk factors for CVD. Currently, there is no effective treatment to prevent CVD complications in SLE. Traditional preventive CVD therapies have not been found to significantly lower the incidence of CVD in SLE; therefore, there is a need for novel treatment strategies and increased understanding of the mechanisms involved in the pathogenesis of CVD complications in SLE. The pathogenic immune responses in SLE and development of atherosclerotic plaques share some characteristics, such as impaired efferocytosis and skewed T cell activation, suggesting the possibility of identifying novel targets for intervention. As novel immune-based therapies for CVD are being developed, it is possible that some of these may be effective for the prevention of CVD and for immunomodulation in SLE. However, further understanding of the mechanisms leading to an increased prevalence of cardiovascular events in SLE is critical for the development of such therapies. This article is protected by copyright. All rights reserved.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng
700a Nilsson, Janu Lund University,Lunds universitet,Kardiovaskulär forskning - immunitet och ateroskleros,Forskargrupper vid Lunds universitet,Cardiovascular Research - Immunity and Atherosclerosis,Lund University Research Groups4 aut0 (Swepub:lu)medf-jni
700a Kaplan, Mariana J4 aut
710a Kardiovaskulär forskning - immunitet och aterosklerosb Forskargrupper vid Lunds universitet4 org
773t Journal of Internal Medicined : Wileyg 278:5, s. 494-506q 278:5<494-506x 1365-2796x 0954-6820
856u https://portal.research.lu.se/files/2423507/8145750.pdfx primaryx freey FULLTEXT
856u http://www.ncbi.nlm.nih.gov/pubmed/25720452?dopt=Abstracty FULLTEXT
856u http://dx.doi.org/10.1111/joim.12357y FULLTEXT
856u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/joim.12357
8564 8u https://lup.lub.lu.se/record/5142633
8564 8u https://doi.org/10.1111/joim.12357

Hitta via bibliotek

Till lärosätets databas

Hitta mer i SwePub

Av författaren/redakt...
Wigren, Maria
Nilsson, Jan
Kaplan, Mariana ...
Om ämnet
MEDICIN OCH HÄLSOVETENSKAP
MEDICIN OCH HÄLS ...
och Klinisk medicin
och Kardiologi
Artiklar i publikationen
Journal of Inter ...
Av lärosätet
Lunds universitet

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy